|
|
||||||||
From the Departments of Obstetrics and Gynecology, Medicine, Community Health and Preventive Medicine, and the Cancer Center, Northwestern University Memorial Hospitals, Prentice Women's Hospital, 333 East Superior, Chicago, Illinois.
Both clinical and laboratory findings suggest that pregnancy constitutes a hypercoagulable condition; yet none of the observed laboratory changes are specific for thrombosis. An essential step involves thrombin-mediated fibrin generation. In the process, fibrinopeptide A (FPA) is cleaved from fibrinogen. Using a radioimmune assay, FPA was determined prospectively in a longitudinal and cross-sectional fashion. Fibrinopeptide A increased significantly over control by the end of the first trimester, from 1.3 ng/ml to 2.8 ng/ml. It continued to increase until 30 to 32 weeks' gestation and then plateaued at 4.3 to 4.7 ng/ml. In the immediate postpartum period, FPA remains elevated. In conclusion, thrombin generation as reflected in FPA production is increased throughout pregnancy, thus confirming a hypercoagulable milieu.
This article has been cited by other articles:
![]() |
M. de Swiet Review Article: Management of pulmonary embolus in pregnancy Eur. Heart J., October 1, 1999; 20(19): 1378 - 1385. [PDF] |
||||
![]() |
S. C. L. Koh, S. Arulkumaran, A. Biswas, and S. S. Ratnam The Influence of Labor and Placental Separation on Hemostasis in Term Pregnancy Clinical and Applied Thrombosis/Hemostasis, October 1, 1998; 4(4): 262 - 267. [Abstract] [PDF] |
||||
![]() |
M. R. Toglia and J. G. Weg Venous Thromboembolism during Pregnancy N. Engl. J. Med., July 11, 1996; 335(2): 108 - 114. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |